Skip to main content
Monday, November 16, 2026Nov 16

World Bank approves $12B to finance virus vaccines, care

FILE - In this Oct. 9, 2020, file photo, a health worker, right, administers the first dose of a COVID-19 vaccine currently on phase III clinical trials to Cem Gun, an emergency medicine physician at the Acibadem Hospital in Istanbul. The World Bank has approved $12 billion in financing to help developing countries buy and distribute coronavirus vaccines, tests, and treatments, aiming to support the vaccination of up to 1 billion people, the bank said in a statement late Tuesday, Oct. 13. (AP Photo/Emrah Gurel, File)
FILE - In this Oct. 9, 2020, file photo, a health worker, right, administers the first dose of a COVID-19 vaccine currently on phase III clinical trials to Cem Gun, an emergency medicine physician at the Acibadem Hospital in Istanbul. The World Bank has approved $12 billion in financing to help developing countries buy and distribute coronavirus vaccines, tests, and treatments, aiming to support the vaccination of up to 1 billion people, the bank said in a statement late Tuesday, Oct. 13. (AP Photo/Emrah Gurel, File)

The World Bank has approved $12 billion in financing to help developing countries buy and distribute coronavirus vaccines, tests, and treatments, aiming to support the vaccination of up to 1 billion people.

The $12 billion “envelope” is part of a wider World Bank Group package of up to $160 billion to help developing countries fight the COVID-19 pandemic, the bank said in a statement late Tuesday.

The World Bank said its COVID-19 emergency response programs are already reaching 111 countries.

Citizens in developing countries also need access to safe and effective COVID-19 vaccines, it said.

“We are extending and expanding our fast-track approach to address the COVID emergency so that developing countries have fair and equal access to vaccines,” said the bank’s president, David Malpass, said in the statement.